Centrus Energy rises 17.5% after Q3 profit beat and enrichment progress

What happened

Centrus Energy (LEU) rose 17.5% on November 6, 2026, after reporting third-quarter profit that topped estimates and after management cited centrifuge shipments and a $7 billion backlog supporting its domestic enrichment expansion. The results included a $46.4M gain from warrants and were reported by Seeking Alpha and Zacks Investment Research. Trading volume on the session was 1.4 times its 20-day average while the S&P 500 rose 0.3%.

How big was the move

The stock’s 17.5% gain was 3.3 times a typical daily move for this stock, a large, mostly company-specific move because it outpaced both the market and its sector. Compared with the Energy sector median, the stock was 16.5 percentage points better on the day; the sector median rose 1.0%. Over the last five sessions the stock rose 1.3%, while the S&P 500 over five sessions fell 2.7%.

The technical picture

Technically the stock remained well below its recent averages. The stock was 3.9% below its 20-day moving average, 23.1% below its 50-day moving average and 41.9% below its 200-day moving average. The 50-day average was below the 200-day average, a sign of a weak longer-term trend. Relative Strength Index (14 days) stood at 42, in a neutral range. The stock was 69.7% below its 52-week high.

Price momentum over medium and longer horizons has been weak. The stock fell 26.4% over one month, fell 44.8% over three months and fell 67.9% over one year, leaving it 76.4 percentage points behind the S&P 500 over the past year. Volatility was 84% annualized over 60 days, which is lower than 56% of its own readings over five years. In the past five years the stock had nine sessions with a gain of at least 17.5%; twenty trading days later the median result was a decline of 9.0%, and four of nine were higher.

Fundamentals and valuation

For the four quarters through September 30, 2026, Centrus Energy reported revenue of $454.5 million, which grew 0.1% from a year earlier. Diluted earnings per share were $3.42, a fall of 48.0% from a year earlier. Gross margin was 22.9% versus 31.8% a year earlier, and operating margin was 1.3% versus 18.2% a year earlier. Free-cash-flow margin was 65.0%.

The balance sheet showed net cash of $1.06 billion and share count over one year increased by 8.4%. Return on invested capital was 0.4%. On valuation, the stock traded at 30.6 times trailing earnings and 42.4 times expected forward earnings, with a free-cash-flow yield of 14.5%. The price-to-earnings reading is higher than 71% of its own readings over the past five years; the five-year median is 15.0 times earnings.

PromtFinance scores ranked the company weak on Value (27), Growth (13), Quality (11), Momentum (5) and Stability (15), with Revisions at 60 (Neutral).

Earnings and analyst expectations

Centrus last reported on November 4, 2026, with earnings per share of $-0.46 against $-0.47 expected, 1.8% above estimates. The company has beaten estimates in three consecutive quarters, though the average surprise over the last four reports was 4.0% below estimates. Typical two-day reactions after recent reports have seen the stock fell 1.6%.

Analysts’ consensus price target is $185.64, which is 77.5% above the closing price. Fifteen analysts covering the stock produce a consensus rating of Hold, with 47% of ratings at Buy or Strong Buy.

What to watch

• Next report: February 9, 2027
• Last report: November 4, 2026: earnings per share of $-0.46 against $-0.47 expected, 1.8% above estimates
• Management cited a $7 billion backlog and new centrifuge shipments, and reported a $46.4M gain from warrants (Seeking Alpha and Zacks Investment Research)
• Trading volume on November 6, 2026, was 1.4 times its 20-day average
• Market value: $2.04 billion